NANJING HANXIN PHARMACEUTICAL TECHNOLOGY CO LTD

Overview

NANJING HANXIN PHARMACEUTICAL TECHNOLOGY CO LTD is an active pharmaceutical ingredient (API) supplier with 3 active FDA Type II Drug Master Files, covering SEMAGLUTIDE DRUG SUBSTANCE; SEMAGLUTIDE MAIN CHAIN P29; TIRZEPATIDE DRUG SUBSTANCE.

API / Drug Master Files

NANJING HANXIN PHARMACEUTICAL TECHNOLOGY CO LTD holds 3 active (3 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.

• TIRZEPATIDE DRUG SUBSTANCEActive2024-12-11
• SEMAGLUTIDE DRUG SUBSTANCEActive2024-09-28
• SEMAGLUTIDE MAIN CHAIN P29Active2024-04-10

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to NANJING HANXIN PHARMACEUTICAL TECHNOLOGY CO LTD in our records. PharmaTek screens the full directory against live FDA enforcement data.